Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease (Helping Hand)
De Quervain Disease
About this trial
This is an interventional treatment trial for De Quervain Disease
Eligibility Criteria
Inclusion Criteria: Male or female patient aged 18 to 75, Patient with unilateral De Quervain's tenosynovitis, Patient cared in the Hand Surgery Department, SOS Mains Emergency Department or Rheumatology Department of Strasbourg University Hospitals, Patient informed of the results of the prior medical examination, Informed consent signed by the patient, Patient affiliated to a health insurance social protection scheme or beneficiary, For a woman of childbearing potential, negative urine pregnancy test at the inclusion visit and maintenance of effective contraception throughout the study. Exclusion Criteria: Pregnant or breastfeeding patient, Patient allergic to a component of the gel with essential oils, Dicloflenac®, NSAIDs, or one of the excipients Patient treated with oral non-steroidal anti-inflammatory drugs Patient with ongoing treatment with another ointment at the treatment application site (radial edge of the wrist) Patient with damaged skin, whatever the lesion: oozing dermatosis, eczema, infected lesion, burn or wound, Patient with atopic skin disease, Patient with epilepsy or with a history of epilepsy, Patient with a history of homolateral De Quervain's tenosynovitis, or having already had corticosteroid infiltrations in the 6 months before his inclusion on the ipsilateral side of the pathology, Patient with associated tendinopathies in the elbow or forearm region, Impossibility of giving the patient information (patient in an emergency situation, patient with difficulties of understandin, agitation of the patient), Patient under legal protection, under guardianship or curatorship.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
active comparator
Experimental Group
Diclofenac gel Splint of the thumb and wrist
Aromatherapy Gel Splint of the thumb and wrist